Pages that link to "Q42990858"

The following pages link to Hepatitis C virus and hepatitis B virus bind to heparin: purification of largely IgG-free virions from infected plasma by heparin chromatography (Q42990858):

Displaying 31 items.

• Viral and cellular determinants involved in hepadnaviral entry (Q24563902) (← links)
• Properties of subviral particles of hepatitis B virus (Q24658234) (← links)
• Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses (Q27473226) (← links)
• Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate Interaction (Q27477606) (← links)
• Sulfated Homologues of Heparin Inhibit Hepatitis C Virus Entry into Mammalian Cells (Q27478383) (← links)
• Characterization of hepatitis C RNA-containing particles from human liver by density and size (Q27486986) (← links)
• Feasibility of Repurposing the Polyanionic Microbicide, PPCM, for Prophylaxis against HIV Transmission during ART (Q34998344) (← links)
• Efficient virus assembly, but not infectivity, determines the magnitude of hepatitis C virus-induced interferon alpha responses of plasmacytoid dendritic cells (Q35110983) (← links)
• Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entry (Q35213305) (← links)
• Interaction of human tumor viruses with host cell surface receptors and cell entry (Q35676027) (← links)
• Molecular virology in transfusion medicine laboratory (Q36766449) (← links)
• Medical virology of hepatitis B: how it began and where we are now (Q37059714) (← links)
• Diagnostic algorithm for HBV safe transfusion (Q37284917) (← links)
• The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership (Q37609487) (← links)
• Secreted Interferon-Inducible Factors Restrict Hepatitis B and C Virus Entry In Vitro (Q37711751) (← links)
• Strategies for antiviral screening targeting early steps of virus infection (Q37801587) (← links)
• Downstream processing of cell culture-derived virus particles (Q37944322) (← links)
• Branched oligosaccharide structures on HBV prevent interaction with both DC-SIGN and L-SIGN. (Q38290950) (← links)
• Visualization of hepatitis B virus entry - novel tools and approaches to directly follow virus entry into hepatocytes (Q38826563) (← links)
• Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans (Q39823787) (← links)
• Multimeric HCV E2 protein obtained from Pichia pastoris cells induces a strong immune response in mice (Q40190351) (← links)
• A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant (Q43440714) (← links)
• Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells (Q45208404) (← links)
• Heparin at physiological concentration can enhance PEG-free in vitro infection with human hepatitis B virus (Q45325445) (← links)
• Removing human immunodeficiency virus (HIV) from human blood using immobilized heparin (Q45360762) (← links)
• Improved particle counting and size distribution determination of aggregated virus populations by asymmetric flow field‐flow fractionation and multiangle light scattering techniques (Q45369277) (← links)
• Macromolecular (pro)drugs in antiviral research (Q57376798) (← links)
• Affinity chromatography for vaccines manufacturing: Finally ready for prime time? (Q88298494) (← links)
• Hypoxia-induced human deoxyribonuclease I is a cellular restriction factor of hepatitis B virus (Q92767464) (← links)
• Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine (Q100415765) (← links)
• The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms (Q110245606) (← links)